TrialHaematologica2010

p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes.

Emilie Frisan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.